Company Data
IN8bio Inc.
Ticker
INAB
Current Price
$1.34 -2.9%
Market Cap
$13.2M
Price Target
Refer to Report
Volume
13.1K
52wk Range
$0.88 - $2.73
Overview
IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.